15:00 CET

Webcast to review the Interim Report Q2 2019

The Interim Report Q2 2019 and an operational update will be presented by CEO Jakob Lindberg and members of Oncopeptides management team, Wednesday August 28, 2019 at 15:00 (CET). The conference call will also be streamed via a link on the website: www.oncopeptides.com.

 

Phone numbers for participants from:
Sweden: +46 8 505 583 59
Europe: +44 3333 009 032
USA: +1 833 823 05 90

 

See link to the webcast: https://tv.streamfabriken.com/oncopeptides-q2-2019

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

63rd ASH Annual Meeting & Exposition

-

American Society of Hematology (ASH) 63rd annual meeting with both in-person and virtual participation at the Georgia World Congress Center in Atlanta, Georgia. ASH Annual Meeting & Exposition is the largest event in malignant and non-malignant hematology.

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-